Henlius, Sandoz Broaden Biosimilar Tie-Up Deal For Up To 10 Products

Henlius and Sandoz have expanded their biosimilar collaboration deal to cover up to 10 products, broadening their partnership in the biopharmaceutical sector.

This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.